DE60144242D1 - Reagens und kit zur bestimmung der globalen gerinnungsfähigkeit und des hämostatischen potentials - Google Patents

Reagens und kit zur bestimmung der globalen gerinnungsfähigkeit und des hämostatischen potentials

Info

Publication number
DE60144242D1
DE60144242D1 DE60144242T DE60144242T DE60144242D1 DE 60144242 D1 DE60144242 D1 DE 60144242D1 DE 60144242 T DE60144242 T DE 60144242T DE 60144242 T DE60144242 T DE 60144242T DE 60144242 D1 DE60144242 D1 DE 60144242D1
Authority
DE
Germany
Prior art keywords
sample
dependent
kit
reagent
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60144242T
Other languages
English (en)
Inventor
Liliana Tejidor
Trevor Baglin
Hema Doobay
Roger Luddington
Timothy J Fischer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge University Hospitals NHS Foundation Trust
Original Assignee
Cambridge University Hospitals NHS Foundation Trust
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge University Hospitals NHS Foundation Trust filed Critical Cambridge University Hospitals NHS Foundation Trust
Application granted granted Critical
Publication of DE60144242D1 publication Critical patent/DE60144242D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60144242T 2000-10-27 2001-10-18 Reagens und kit zur bestimmung der globalen gerinnungsfähigkeit und des hämostatischen potentials Expired - Lifetime DE60144242D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/698,589 US6645768B1 (en) 2000-10-27 2000-10-27 Reagent and kit for determining global coagulability and hemostatic potential
PCT/US2001/032563 WO2002034109A2 (en) 2000-10-27 2001-10-18 A reagent and kit for determining global coagulability and hemostatic potential

Publications (1)

Publication Number Publication Date
DE60144242D1 true DE60144242D1 (de) 2011-04-28

Family

ID=24805872

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60144242T Expired - Lifetime DE60144242D1 (de) 2000-10-27 2001-10-18 Reagens und kit zur bestimmung der globalen gerinnungsfähigkeit und des hämostatischen potentials

Country Status (11)

Country Link
US (2) US6645768B1 (de)
EP (1) EP1337858B1 (de)
JP (1) JP4065195B2 (de)
AT (1) ATE502303T1 (de)
AU (2) AU2002215382B2 (de)
BR (1) BR0114942A (de)
CA (1) CA2427297A1 (de)
DE (1) DE60144242D1 (de)
ES (1) ES2363210T3 (de)
MX (1) MXPA03003683A (de)
WO (1) WO2002034109A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743596B1 (en) * 2000-10-27 2004-06-01 Biomerieux, Inc. Method of determining global coagulability hemostatic potential
EP1546710A4 (de) 2002-09-10 2011-05-25 Placor Inc Verfahren und vorrichtung für die berwachung der thrombozytenfunktion
WO2005017486A2 (en) * 2003-06-09 2005-02-24 Mann Kenneth G A global test of the hemostatic system
CA2566411A1 (en) * 2004-05-11 2005-11-24 Heptest Laboratories, Inc. Compositions, kit and one-step method for monitoring compounds having anti-factor xa and/or anti factor iia activities
EP1875232A2 (de) * 2005-04-25 2008-01-09 PlaCor, Inc. Verfahren und vorrichtungen zur überwachung der blutplättchenfunktion
EP2380905A1 (de) * 2010-04-19 2011-10-26 Thrombotargets Europe, S.L. Phospholipidangereicherte Vesikel mit Gewebefaktor mit blutstillenden Aktivitäten sowie Verwendungen davon
US20140242707A1 (en) * 2011-07-21 2014-08-28 Philadelphia Health & Education Corporation D/B/A Drexel University College Of Medicine Compositions and Methods for Diagnosing Hypercoagulability and Hypocoagulability
US10188302B2 (en) * 2011-12-31 2019-01-29 The University Of Vermont And State Agriculture College Methods for dynamic visualization of clinical parameters over time
ES2959277T3 (es) * 2016-05-13 2024-02-22 Scripps Research Inst Composiciones y métodos para terapias antitrombóticas y hemostáticas
RU2660706C1 (ru) * 2017-09-26 2018-07-09 федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр профилактической медицины" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ ПМ" Минздрава России) Скрининг-тест определения контактного пути коагуляции (СТОКПК)
JP6952668B2 (ja) * 2018-09-28 2021-10-20 シスメックス株式会社 血液凝固分析方法、血液凝固分析装置、プログラム
EP3983810A1 (de) 2019-06-15 2022-04-20 Academisch Medisch Centrum Verfahren zur bestimmung der gefahr eines thromboembolischen ereignisses
JPWO2022145477A1 (de) * 2020-12-28 2022-07-07

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208479A (en) * 1977-07-14 1980-06-17 Syva Company Label modified immunoassays
NL8902406A (nl) 1989-09-27 1991-04-16 Hendrik Coenraad Hemker Prof D Werkwijze voor het bepalen van de endogene trombinepotentiaal van plasma, en bloed alsmede een bij deze werkwijze te gebruiken kit.
US5646046A (en) 1989-12-01 1997-07-08 Akzo Nobel N.V. Method and instrument for automatically performing analysis relating to thrombosis and hemostasis
JPH04228648A (ja) * 1990-12-27 1992-08-18 Bridgestone Corp エアバッグ
DE69224622T2 (de) 1991-10-04 1998-11-05 Dade Behring Inc Herstellung von prothrombinzeit-reagenzien aus rekombinantem menschlichem gewebefaktor und sythetischen phospholipiden
US5716795A (en) 1991-10-04 1998-02-10 Matschiner; John T. Thrombomodulin-based coagulometric assay of the protein C system
DE4133946A1 (de) 1991-10-14 1993-04-15 Behringwerke Ag Funktioneller test und reagenz zur bestimmung von fibrinogen
SE470274B (sv) 1991-11-13 1993-12-20 Bjoern Dahlbaeck Användning av en in vitro-metod för diagnos av blodkoagulationssjukdomar
JP3224607B2 (ja) 1992-09-11 2001-11-05 株式会社アズウェル 血液凝固第ｘｉｉｉ因子活性測定方法および該測定用試薬キット
US5472852A (en) 1993-09-15 1995-12-05 Oklahoma Medical Research Foundation Assay for detection of selective Protein C inhibition by patients
DE4427785A1 (de) 1994-08-08 1996-02-15 Behringwerke Ag Verfahren zum Nachweis von Störungen des Protein C/Protein S-Systems
ATE198772T1 (de) 1994-11-10 2001-02-15 Dade Behring Marburg Gmbh Verfahren zum spezifischen nachweis eines aktivierten gerinnungsfaktors v mit einer erhöhten stabilität gegenüber aktiviertem protein c
WO1998048283A1 (en) * 1997-04-23 1998-10-29 Instrumentation Laboratory S.P.A. Recombinant rabbit tissue factor based prothrombin time reagent
DE19749197A1 (de) * 1997-11-07 1999-05-12 Dade Behring Marburg Gmbh Verfahren zur Bestimmung des antikoagulatorischen Potentials einer Probe
US6245573B1 (en) * 1998-02-12 2001-06-12 University Of Medicine And Dentistry Of New Jersey Rapid assessment of the coagulant activity of blood
ATE274600T1 (de) * 1998-06-08 2004-09-15 Univ Vermont Verfahren zur bestimmung der blutgerinnung in plasma
US6627193B1 (en) * 1999-01-13 2003-09-30 University Of Georgia Research Foundation, Inc. Methods and compositions for control of blood coagulation

Also Published As

Publication number Publication date
AU1538202A (en) 2002-05-06
ATE502303T1 (de) 2011-04-15
EP1337858A4 (de) 2005-08-17
CA2427297A1 (en) 2002-05-02
AU2002215382B2 (en) 2005-11-24
WO2002034109A3 (en) 2002-08-15
US6645768B1 (en) 2003-11-11
US20050191751A1 (en) 2005-09-01
EP1337858B1 (de) 2011-03-16
MXPA03003683A (es) 2003-08-07
WO2002034109A2 (en) 2002-05-02
BR0114942A (pt) 2003-12-23
JP4065195B2 (ja) 2008-03-19
ES2363210T3 (es) 2011-07-27
JP2004512511A (ja) 2004-04-22
EP1337858A2 (de) 2003-08-27

Similar Documents

Publication Publication Date Title
WO2002034110A3 (en) Method of determining global coagulability and hemostatic potential
Kitchen et al. Measurement of non-coumarin anticoagulants and their effects on tests of Haemostasis: Guidance from the British Committee for Standards in Haematology.
Sosothikul et al. Activation of endothelial cells, coagulation and fibrinolysis in children with Dengue virus infection
Habib et al. Evidence of rebalanced coagulation in acute liver injury and acute liver failure as measured by thrombin generation
DE60144242D1 (de) Reagens und kit zur bestimmung der globalen gerinnungsfähigkeit und des hämostatischen potentials
Raffa et al. Hypercoagulability in patients with chronic noncirrhotic portal vein thrombosis
ES2088992T3 (es) Metodo para determinar los niveles de factores de coagulacion intrinsecos y extrinsecos y proteina c.
O'Leary et al. A turbidimetric assay for the measurement of clotting times of procoagulant venoms in plasma
Nielsen et al. Elastic modulus-based thrombelastographic quantification of plasma clot fibrinolysis with progressive plasminogen activation
Debaugnies et al. Evaluation of the procoagulant activity in the plasma of cancer patients using a thrombin generation assay
Scarlatescu et al. The current status of viscoelastic testing in septic coagulopathy
Van Veen et al. Calibrated automated thrombin generation and modified thromboelastometry in haemophilia A
Boknäs et al. Contact activation: important to consider when measuring the contribution of tissue factor‐bearing microparticles to thrombin generation using phospholipid‐containing reagents
Hassan et al. Coagulation abnormalities in dengue and dengue haemorrhagic fever patients
JP7393006B2 (ja) フィブリノーゲン検査
Puckett et al. Magnetoelastic transducers for monitoring coagulation, clot inhibition, and fibrinolysis
Adams Assessment of thrombin generation: useful or hype?
DeLoughery Tests of hemostasis and thrombosis
Chandler Laboratory techniques in fibrinolysis testing
Key et al. Views on methods for monitoring recombinant factor VIIa in inhibitor patients
Konkle Monitoring target specific anticoagulants
Nair et al. Hemostatic testing in critically ill infants and children
Eichinger Thrombin generation and venous thromboembolism
Lippi et al. Urgent monitoring of dabigatran plasma levels: sometimes less is more
Anatoliivna et al. DETERMINATION OF THE MOST INFORMATIVE INDICATORS OF HEMOSTASIS, FOR ASSESSING THE CONDITION OF PATIENTS WITH HEARING LOSS CAUSED BY ACUTRAUMATIC OBJECTIVES